Department of Surgery, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Japan.
Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
BMC Cancer. 2022 Aug 1;22(1):839. doi: 10.1186/s12885-022-09842-4.
Inflammatory indices and tumor-infiltrating lymphocytes (TILs) have prognostic value in many cancer types. This study aimed to assess the prognostic value of inflammatory indices and evaluate their correlation with survival and presence of TILs in patients with colorectal liver metastasis (CRLM).
Medical records of 117 patients who underwent hepatectomy for CRLM were retrospectively reviewed. We calculated inflammatory indices comprising the neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, C-reactive protein/albumin ratio (CAR), and Glasgow prognostic score (GPS). Furthermore, we evaluated the relationship between these ratios and the GPS and survival rates and immunohistochemical results of tumor-infiltrating CD3+, CD8+, and Foxp3+ lymphocytes.
The patients with low CAR values and low GPS had significantly better overall survival as per the log-rank test (p = 0.025 and p = 0.012, respectively). According to the multivariate analysis using the Cox proportional hazard model, the CAR (hazard ratio [HR], 0.57; 95% confidence interval [CI], 0.33-0.99; p = 0.048) and GPS (HR, 0.40; 95% CI, 0.19-0.83; p = 0.013) were independent prognostic factors. Additionally, Foxp3+ lymphocytes were more common in samples from the patients with a low CAR (p = 0.041). Moreover, the number of CD3+ TILs was significantly higher in the patients with a low GPS (p = 0.015).
The CAR and GPS are simple, inexpensive, and objective markers associated with predicting survival in patients with CRLM. Moreover, they can predict the presence of Foxp3+ and CD3+ lymphocytes in the invasive margin of a tumor.
Retrospectively registered. https://www.kurume-u.ac.jp/uploaded/attachment/14282.pdf .
炎症指标和肿瘤浸润淋巴细胞(TILs)在许多癌症类型中具有预后价值。本研究旨在评估炎症指标的预后价值,并评估其与结直肠癌肝转移(CRLM)患者生存和 TILs 存在的相关性。
回顾性分析 117 例接受肝切除术治疗 CRLM 的患者的病历。我们计算了包含中性粒细胞/淋巴细胞比值、血小板/淋巴细胞比值、C 反应蛋白/白蛋白比值(CAR)和格拉斯哥预后评分(GPS)在内的炎症指标。此外,我们评估了这些比值与 GPS 和生存率之间的关系,并评估了肿瘤浸润 CD3+、CD8+和 Foxp3+淋巴细胞的免疫组化结果。
根据对数秩检验,低 CAR 值和低 GPS 的患者的总生存率明显更好(p=0.025 和 p=0.012)。根据 Cox 比例风险模型的多变量分析,CAR(风险比 [HR],0.57;95%置信区间 [CI],0.33-0.99;p=0.048)和 GPS(HR,0.40;95%CI,0.19-0.83;p=0.013)是独立的预后因素。此外,低 CAR 组中 Foxp3+淋巴细胞更为常见(p=0.041)。此外,低 GPS 组中 CD3+TIL 数量明显更高(p=0.015)。
CAR 和 GPS 是简单、廉价和客观的标志物,与预测 CRLM 患者的生存有关。此外,它们可以预测肿瘤浸润边缘处 Foxp3+和 CD3+淋巴细胞的存在。
回顾性注册。https://www.kurume-u.ac.jp/uploaded/attachment/14282.pdf。